Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and the Effects of Ixodes Ricinus-Contact Phase Inhibitor (Ir-CPI) in Adult Patients With Spontaneous Intracerebral Haemorrhage [Phase 2]

View source ↗

Summary

This entry notes a Phase 2 study evaluating the safety, tolerability and effects of Ixodes Ricinus-Contact Phase Inhibitor (Ir-CPI) in adult patients with spont…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage

Drugs mentioned

• Ixodes Ricinus-Contact Phase Inhibitor (Ir-CPI) (Ir-CPI)

Snippet

Sponsor: Bioxodes S.A. | Conditions: Intracerebral Hemorrhage | Phase 2 | Status: ACTIVE_NOT_RECRUITING